These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 11739150)

  • 21. Reconstruction of the immune system after unrelated or partially matched T-cell-depleted bone marrow transplantation in children: immunophenotypic analysis and factors affecting the speed of recovery.
    Kook H; Goldman F; Padley D; Giller R; Rumelhart S; Holida M; Lee N; Peters C; Comito M; Huling D; Trigg M
    Blood; 1996 Aug; 88(3):1089-97. PubMed ID: 8704219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities.
    Champlin RE; Passweg JR; Zhang MJ; Rowlings PA; Pelz CJ; Atkinson KA; Barrett AJ; Cahn JY; Drobyski WR; Gale RP; Goldman JM; Gratwohl A; Gordon-Smith EC; Henslee-Downey PJ; Herzig RH; Klein JP; Marmont AM; O'Reilly RJ; Ringdén O; Slavin S; Sobocinski KA; Speck B; Weiner RS; Horowitz MM
    Blood; 2000 Jun; 95(12):3996-4003. PubMed ID: 10845940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of immune reconstitution in children undergoing cord blood transplantation.
    Moretta A; Maccario R; Fagioli F; Giraldi E; Busca A; Montagna D; Miniero R; Comoli P; Giorgiani G; Zecca M; Pagani S; Locatelli F
    Exp Hematol; 2001 Mar; 29(3):371-9. PubMed ID: 11274766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children.
    Sánchez-Ramón S; Bellón JM; Resino S; Cantó-Nogués C; Gurbindo D; Ramos JT; Muñoz-Fernández MA
    Pediatrics; 2003 Feb; 111(2):E168-75. PubMed ID: 12563091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival.
    Myers LA; Patel DD; Puck JM; Buckley RH
    Blood; 2002 Feb; 99(3):872-8. PubMed ID: 11806989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease.
    Körbling M; Huh YO; Durett A; Mirza N; Miller P; Engel H; Anderlini P; van Besien K; Andreeff M; Przepiorka D; Deisseroth AB; Champlin RE
    Blood; 1995 Oct; 86(7):2842-8. PubMed ID: 7545476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular interactions in marrow-grafted patients. II. Normal monocyte antigen-presenting and defective T-cell-proliferative functions early after grafting and during chronic graft-versus-host disease.
    Tsoi MS; Dobbs S; Brkic S; Ramberg R; Thomas ED; Storb R
    Transplantation; 1984 Jun; 37(6):556-61. PubMed ID: 6233768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
    Atanackovic D; Cao Y; Luetkens T; Panse J; Faltz C; Arfsten J; Bartels K; Wolschke C; Eiermann T; Zander AR; Fehse B; Bokemeyer C; Kroger N
    Haematologica; 2008 Mar; 93(3):423-30. PubMed ID: 18287134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allogeneic hematopoietic stem cell transplantation recipients have defects of both switched and igm memory B cells.
    D'Orsogna LJ; Wright MP; Krueger RG; McKinnon EJ; Buffery SI; Witt CS; Staples N; Loh R; Cannell PK; Christiansen FT; French MA
    Biol Blood Marrow Transplant; 2009 Jul; 15(7):795-803. PubMed ID: 19539210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allogeneic bone marrow grafts with high levels of CD4(+) CD25(+) FoxP3(+) T cells can lead to engraftment failure.
    Fricke S; Rothe K; Hilger N; Ackermann M; Oelkrug C; Fricke C; Schönfelder U; Niederwieser D; Emmrich F; Sack U
    Cytometry A; 2012 Jun; 81(6):476-88. PubMed ID: 22522779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Larger numbers of CD4(bright) dendritic cells in donor bone marrow are associated with increased relapse after allogeneic bone marrow transplantation.
    Waller EK; Rosenthal H; Jones TW; Peel J; Lonial S; Langston A; Redei I; Jurickova I; Boyer MW
    Blood; 2001 May; 97(10):2948-56. PubMed ID: 11342416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Partial review of immunotherapeutic pharmacology in stem cell transplantation.
    Bierman PJ; Abe F; Buyukberber S; Ino K; Talmadge JE
    In Vivo; 2000; 14(1):221-36. PubMed ID: 10757081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
    Li JM; Waller EK
    Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of T-, B- and NK-cell reconstitution following conventional or nonmyeloablative conditioning and transplantation with bone marrow or peripheral blood stem cells from human leucocyte antigen identical sibling donors.
    Petersen SL; Ryder LP; Björk P; Madsen HO; Heilmann C; Jacobsen N; Sengeløv H; Vindeløv LL
    Bone Marrow Transplant; 2003 Jul; 32(1):65-72. PubMed ID: 12815480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical changes in sigmoid colon after allogeneic and autologous bone marrow transplantation.
    Forbes GM; Erber WN; Herrmann RP; Davies JM; Collins BJ
    J Clin Pathol; 1995 Apr; 48(4):308-13. PubMed ID: 7615847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endogenous superantigens in allogeneic bone marrow transplant recipients rapidly and selectively expand donor T cells which can produce IFN-gamma.
    Jones MS; Riley R; Hamilton BL; Paupe J; Perez D; Levy RB
    Bone Marrow Transplant; 1994 Nov; 14(5):725-35. PubMed ID: 7889005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Continuing observations on the regulatory effects of donor-specific bone marrow cell infusions and chimerism in kidney transplant recipients.
    Garcia-Morales R; Carreno M; Mathew J; Cirocco R; Zucker K; Ciancio G; Burke G; Roth D; Temple D; Fuller L; Esquenazi V; Eskind L; Kenyon NS; Ricordi C; Tzakis A; Miller J
    Transplantation; 1998 Apr; 65(7):956-65. PubMed ID: 9565101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Changes in peripheral lymphocyte subfraction in cytomegalovirus infections during the early stage of allogenic peripheral blood stem cell transplantation].
    Li TS; Qin HY; Chen H; Jiang M; Wang HL; Wang AX
    Zhonghua Nei Ke Za Zhi; 2003 Jun; 42(6):396-9. PubMed ID: 12895323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recovery of mononuclear cell subsets after bone marrow transplantation: overabundance of CD4+CD8+ dual-positive T cells reminiscent of ontogeny.
    Storek J; Ferrara S; Rodriguez C; Saxon A
    J Hematother; 1992; 1(4):303-16. PubMed ID: 1345675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Flow cytometric analysis of T lymphocyte subsets after human bone marrow transplantation using monoclonal antibodies and dual immunofluorescence].
    Matsue K; Yasue S; Iwabuchi K; Ohtsuka M; Ueda M; Kondo K; Shiobara S; Mori T; Matsuda T; Harada M
    Nihon Ketsueki Gakkai Zasshi; 1989 May; 52(3):659-64. PubMed ID: 2694718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.